Roche says Phase 3 studies for Alzheimer’s drug failed to meet primary endpoints
admin Roche Holding AG said Monday that Phase 3 Graduate studies of gantenerumab, for treatment of…
Read MoreRoche
Roche backs 2022 outlook as profit climbs, boosted by diagnostics sales
Roche Holding AG said Thursday that profit for the first half of the year increased…
Read More